Cover
Vol. 9 No. 2 (2019)

Published: December 31, 2019

Pages: 39-54

Research Article

Effects of Vaginal Misoprostol after Intrauterine Insemination IUI

Zahraa H. Mohan 1 Nadia M. Al-Hilli 2 Mohammad Oda Selman
1The High Institute of Infertility Diagnosis and Assisted Reproductive Technologies, Al-Nahrain University, Baghdad, Iraq
2College of medicine, University of Babylon, Babylon, Iraq
History
  • Received: September 26, 2019
  • Accepted: May 1, 2020
  • Available Online: May 6, 2020
DOI

https://doi.org/10.28969/IJEIR.v9.i2.r3

Abstract

Intrauterine insemination has an important role in the treatment of infertile couples. Usage of vaginal misoprostol therapy at the time of intrauterine insemination has been investigated, and its tolerability and effects on clinical pregnancy rates still questionable. To assess the effectiveness of vaginal misoprostol on some demographic characteristics and hormones level with a success rate of Intrauterine Insemination. the period of collection of patients extended from Sep. 2018 until May 2019. Eighty-one infertile couples who attended Al Nahrain University, High Institute for Diagnostic Infertility and Assisted Reproductive Technologies, and private fertility clinics were enrolled through this study. Divided into two groups, the next group received 100 µg vaginal misoprostol immediately after completion of the IUI procedure, while the control group was subjected to ordinary IUI procedure without adjunctive therapy. The mean of demographic data of body mass index, age, and duration of infertility was statistically insignificant in control, Misoprostol post-intrauterine insemination. The percentage of pregnancy rate in the control group 5.0% and it 19.5% in the Misoprostol post-intrauterine insemination group. Moreover, there are significant differences in pregnancy rates among all study groups. According to this study, there is no significant result of pregnancy occurrences correlated with, female age, male age, and body mass index, duration of infertility or type of infertility, hormone levels. Misoprostol use after intrauterine insemination has a positive impact on pregnancy outcome in the control group 5.0% and it 19.5% in Misoprostol post-intrauterine insemination group. Smaller doses (100 µg) of misoprostol can decrease side effects without affecting the outcome.

Keywords

References

  1. World Health Organization (WHO). Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction, 5th ed. Cambridge University Press. Cambridge, UK. 2010. [WHO]
  2. Bickerstaff HMD. 20th ed. by Ten Teachers. 2017, Chapter 7;153-154. [PDF]
  3. Abbara A, Clarke SA, Dhillo WS. Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment. Endocrine Reviews. The Endocrine Society; 2018;39(5):593–628. Doi: http://dx.doi.org/10.1210/er.2017- 00236 [PubMed][PMC][OxFord]
  4. Sarapik A, Velthut A, Haller- Kikkatalo K, Faure GC, Béné M-C, de Carvalho Bittencourt M, et al. Follicular Proinflammatory Cytokines and Chemokines as Markers of IVF Success. Clinical and Developmental Immunology. Hindawi Limited; 2012;2012:1–10. Doi: http://dx.doi.org/10.1155/2012/60645 9 [Hindawi][PMC][PubMed]
  5. Liu J, Li T-C, Wang J, Wang W, Hou Z, Liu J. The impact of ovarian stimulation on the outcome of intrauterine insemination treatment: an analysis of 8893 cycles. BJOG: An International Journal of Obstetrics & Gynaecology. Wiley; 2016;123:70–5. Doi: http://dx.doi.org/10.1111/1471- 0528.14020 [PubMed][Wiley]
  6. Cytotec. (Misoprostol oral tablets). (2016). New York, NY; G.D. Searle Inc. [URL]
  7. Yount SM, Lassiter N. The Pharmacology of Prostaglandins for Induction of Labor. Journal of Midwifery & Women’s Health. Wiley; 2013;58(2):133–44. Doi: http://dx.doi.org/10.1111/jmwh.12022 [PubMed][Wiley]
  8. Bygdeman M. Pharmacokinetics of prostaglandins. Best Practice & Research Clinical Obstetrics & Gynaecology. Elsevier BV; 2003;17(5):707–16. Doi: http://dx.doi.org/10.1016/s1521- 6934(03)00043-9 [PubMed][Elsevier]
  9. Nuttall FQ. Body Mass Index. Nutrition Today. Ovid Technologies (Wolters Kluwer Health); 2015;50(3):117–28. Doi: http://dx.doi.org/10.1097/nt.00000000 00000092 [PubMed][PMC]
  10. Hull MGR, Savage PE, Bromham DR, Ismail AAA, Morris AF. The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle (“ovulation”) derived from treated and untreated conception cycles. Fertility and Sterility. Elsevier BV; 1982;37(3):355–60. Doi: http://dx.doi.org/10.1016/s0015- 0282(16)46095-4 [PubMed][Elsevier]
  11. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, et al. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Human Reproduction. Oxford University Press (OUP); 2008;24(4):867–75. Doi: http://dx.doi.org/10.1093/humrep/den 480 [PubMed][Elsevier]
  12. Hindal AS, Mossa HAL, Abood MS. Reactive Oxygen Species Levels in Seminal Plasma in a Sample of Iraqi Infertile Men using Advanced Stimulatory Method for Activation of Spermatozoa International Journal of Medical Research & Health Sciences, 2018, 7(12): 51-55. [IJMRHS]
  13. Dujaily SS, Al–Dahan S. Gender selection by Ericson method following IUI for infertile couples. Iraq, J. S. C. Med. 2012;12(1):25-30. [PDF]
  14. Gardner DK, Weissman A, Howles CM, Shoham Z. Textbook of Assisted Reproductive Techniques, Fifth Edition. CRC Press; 2017; Doi: http://dx.doi.org/10.1201/9781351228 244 [Taylor&Francis]
  15. Zhang R, Linpeng S, Li Z, Cao Y, Tan H, Liang D, et al. Deficiency in GnRH receptor trafficking due to a novel homozygous mutation causes idiopathic hypogonadotropic hypogonadism in three prepubertal siblings. Gene. Elsevier BV; 2018;669:42–6. Doi: http://dx.doi.org/10.1016/j.gene.2018. 05.050 [PubMed][Elsevier]
  16. Malizia BA, Hacker MR, Penzias AS. Cumulative Live-Birth Rates after In Vitro Fertilization. New England Journal of Medicine. Massachusetts Medical Society; 2009;360(3):236–43. Doi: http://dx.doi.org/10.1056/nejmoa0803 072 [NEJM]
  17. Ahmed M, Shareef O, Adam I, Rayis D. Maternal age and intracytoplasmic sperm injection outcome in infertile couples at Khartoum, Sudan. F1000Research. F1000 Research Ltd; 2015;4:1339. Doi: http://dx.doi.org/10.12688/f1000resea rch.7386.1 [PubMed][PMC][F1000]
  18. Tan T, Lau S, Loh S, Tan H. Female ageing and reproductive outcome in assisted reproduction cycles. Singapore Medical Journal. Singapore Medical Journal; 2014;55(6). Doi: http://dx.doi.org/10.11622/smedj.2014 081 [PubMed][PMC][SJM]
  19. Yavuz A, Demirci O, Sözen H, Uludoğan M. Predictive factors influencing pregnancy rates after intrauterine insemination. Iran J. Reprod. Med. 2013;11(3):227–234. [PMC]
  20. Isa AM, Abu-Rafeam B, Alasirim SA, Binsalehm S, Ismail KH, Vilosm GA. Age, body mass index, and number of previous trials: are they prognosticators of intra-uterine- insemination for infertility treatment. Int. J. Fertil. Steril. 2014;8(3):255– 260. [PMC]
  21. Huyghe S, Verest A, Thijssen A, Ombelet W. Influence of BMI and smoking on IUI outcome with partner and donor sperm. Facts Views Vis Obgyn. 2017;9(2): 93–100. [PMC]
  22. Soria M, Pradillo G, García J, Ramón P, Castillo A. Pregnancy predictors after intrauterine insemination: Analysis of 3012 Cycles in 1201 Couples. J. Reprod. Infertil. 2012;13:158-166. [PubMed][PMC]
  23. Peivandi S, Ebadi A, Modanlu S. The comparison between Intrauterine Insemination and Fallopian Tube Sperm Perfusion Using FAST®System in Patients with Unexplained Infertility. Int. J. Fertil Steril. 2015;8(4):379–384. [PMC][ResearchGate]
  24. Wadhwa L, Fauzdar A, Wadhwa SN. An Intrauterine Insemination Audit at Tertiary Care Hospital: A 4½ Years' Retrospective Analysis of 800 Intrauterine Insemination Cycles. J Hum Reprod Sci. 2018;11(3):279– 285. Doi: https://doi.org/10.4103/jhrs.jhrs_34_1 8 [PubMed][PMC][Wolters Kluwer]
  25. Ganguly I, Singh A, Bhandari S, Agrawal P, Gupta N. Pregnancy Predictors after Intrauterine Insemination in Cases of Unexplained Infertility: A Prospective Study. International Journal of Reproductive Medicine. Hindawi Limited; 2016;2016:1–5. Doi: http://dx.doi.org/10.1155/2016/58178 23 [PubMed][PMC][Hindawi]
  26. Thomsen LH, Humaidan P, Erb K, Overgaard M, Andersen CY, Kesmodel US. Mid-Luteal 17-OH Progesterone Levels in 614 Women Undergoing IVF-Treatment and Fresh Embryo Transfer—Daytime Variation and Impact on Live Birth Rates. Frontiers in Endocrinology. Frontiers Media SA; 2018;9. Doi: http://dx.doi.org/10.3389/fendo.2018. 00690 [PubMed][PMC][Frontiersin]
  27. Weiss NS, van Vliet MN, Limpens J, Hompes PGA, Lambalk CB, Mochtar MH, et al. Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta-analysis. Human Reproduction. Oxford University Press (OUP); 2017;32(5):1009–18. Doi: http://dx.doi.org/10.1093/humrep/dex 035 [PubMed] [OxFord]
  28. Liu Y, Ye XY, Chan C. The association between endometrial thickness and pregnancy outcome in gonadotropin-stimulated intrauterine insemination cycles. Reproductive Biology and Endocrinology. Springer Science and Business Media LLC; 2019;17(1). Doi: http://dx.doi.org/10.1186/s12958-019- 0455-1 [PubMed][PMC][BMC]
  29. Kolibianakis E, Zikopoulos K, Fatemi H, Osmanagaoglu K, Evenpoel J, Van Steirteghem A, et al. Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reproductive BioMedicine Online. Elsevier BV; 2004;8(1):115–8. Doi: http://dx.doi.org/10.1016/s1472- 6483(10)60505-6 [PubMed][Elsevier]
  30. Habibzadeh V, Nematolahi Mahani SN, Kamyab H. The correlation of factors affecting the endometrial thickness with pregnancy outcome in the IUI cycles. Iran J Reprod Med. 2011;9(1):41–46. [PMC]
  31. Richter KS, Bugge KR, Bromer JG Levy MJ. Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertility and Sterility. Elsevier BV; 2007;87(1):53–9. Doi: http://dx.doi.org/10.1016/j.fertnstert.2 006.05.064 [PubMed][Elsevier]
  32. Brown SE, Toner JP, Schnorr JA, Williams SC, Gibbons WE, de Ziegler D, et al. Vaginal misoprostol enhances intrauterine insemination. Human Reproduction. Oxford University Press (OUP); 2001;16(1):96–101. Doi: http://dx.doi.org/10.1093/humrep/16.1 .96 [PubMed][OxFord][ResearchGate]
  33. Moslemizadeh N, Moghadam TG, Peyvandi S. Evaluation of vaginal misoprostol effect on pregnancy rate after intrauterine insemination. Pak J Biol Sci. 2009;12:64–68. [Scialert]
  34. Barroso G, karchmer S, Castelzo E, Carball E, Kably A. A prospective randomized trial of the impact of misoprostol (PgE1) on pregnancy rat after intrauterine insemination (IUI) therapy: a preliminary report. Ginecol Obstet Mex. 2001;69:346–350. [PubMed]
  35. Chikkagowdra S, Patted SS, Desai BR. Randomized controlled trial on effect of vaginal misoprostol as an adjuvant after intra uterine insemination. Int J Health Sci Res. 2013;3: 24–28. [IJHSR]
  36. Zahiri SZ, Asgharnia M, Gholampoor A. Effect of vaginal misoprostol on pregnancy rate after intrauterine insemination: a randomized controlled trial. Iran J Reprod Med. 2015;13(1):9–14. [PubMed][PMC] Biography Zahraa Hamid Mohan She was born in Babylon. Iraq in 1992 (BVM) is a graduate from the Al-Qasim Green university college of veterinary medicine, graduated in 2016. she is an M.Sc. student in Applied Embryology at Al Nahrain University, the High Institute of Infertility Diagnosis, and Assisted Reproductive Technologies. Dr. Nadia Mudher Sulaiman Al-Hilli She was born in Babylon, Iraq in 1976. She received the M.B.Ch.B. from College of Medicine, the University of Babylon in 1999, the Diploma in Obstetrics & Gynecology in 2005, Iraqi Board in Obstetrics & Gynecology (FIBMS) in 2006, the Part I MRCOG in 2006, and the Certificate of minimal access surgery from the Iraqi Ministry of Health in 2017. Currently, she is an Assistant Professor and the Head of the department in Obstetrics & Gynecology department, College of Medicine, University of Babylon. She is also a lecturer and supervisor of Ph.D. students in the High Institute of Infertility and Assisted Reproductive Technologies since 2016. She is a member of the medical education committee at the University of Babylon, College of Medicine, and a member of the scientific committee of Obs. & Gyne. department at the University of Babylon, College of Medicine. She participated in more than, 25 Symposiums, 3 International Symposiums, 18 National Conferences, 15 International Conferences, 16 Workshops, and 9 Training Courses. She published more than 21 articles both local and international. She has more than 200 diagnostic & operative hysteroscopy operations & More than 200 diagnostic and operative laparoscopies performed for infertility patients. Dr. Mohammad Oda Selman He is a professor of Applied Embryology in the High Institute for Infertility Diagnosis and ART, Al-Nahrain University. He has more than 70 published articles both local and international. He supervised many M.Sc. and Ph.D. students How to cite: Mohan ZH, Al-Hilli NMS, Selman MO. Effects of Vaginal Misoprostol after Intrauterine Insemination IUI; Iraqi Journal of Embryos and Infertility Researches (IJEIR), (2019); 9(2): 39-54. Doi: http://doi.org/10.28969/IJEIR.v9.i2.r3 © 2019 Author(s)